Catalio Capital Management, LP — 13F Holdings & Portfolio

CIK 1958125 · latest 13F-HR filed 2026-08-14

Catalio Capital Management, LP manages $532.1M in 13F-reported U.S. long-equity assets across 39 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are AVLN (10.37%), JNJ (6.63%), GILD (6.39%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 11 new positions and exited 13; 20 existing positions rose in reported value and 7 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$532.1M

Long-equity book

Holdings
39

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+11 / −13 / ↑20 / ↓7

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 56.7%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Mar 31, 2026.

Assets Under Management
$2.18B
Discretionary
$1.93B
Employees
30
Accounts
33
Address
512 W. 22ND STREET
5TH FLOOR
NEW YORK, NY 10011
Phone
(410) 989-6168
Name Title / Status Ownership Type
CATALIO CAPITAL GP, LLC ControlGENERAL PARTNER
since Jun 2020
Less than 5%Domestic Entity
KKR CATALINA HOLDINGS L.P. ControlLIMITED PARTNER
since Oct 2023
25–50%Domestic Entity
STONEBIRD PARTNERS, LP ControlLIMITED PARTNER
since Jan 2023
50–75%Domestic Entity
MALTSEVA, OLGA, EDUARDOVNACHIEF COMPLIANCE OFFICER AND HEAD OF OPERATIONS
since Jun 2021
Less than 5%Individual
KKR & CO. INC. Control
Indirect owner via KKR GROUP CO. INC.
SHAREHOLDER
since Oct 2023
75% or moreDomestic Entity
KKR CATALINA GP LLC Control
Indirect owner via KKR CATALINA HOLDINGS L.P.
GENERAL PARTNER
since Oct 2023
General partner, trustee or managerDomestic Entity
KKR GROUP ASSETS GP II LLC Control
Indirect owner via KKR GROUP ASSETS HOLDINGS II L.P.
GENERAL PARTNER
since Oct 2023
General partner, trustee or managerDomestic Entity
KKR GROUP ASSETS HOLDINGS II L.P. Control
Indirect owner via KKR CATALINA GP LLC
SOLE MEMBER
since Oct 2023
75% or moreDomestic Entity
KKR GROUP ASSETS HOLDINGS II L.P. Control
Indirect owner via KKR CATALINA HOLDINGS L.P.
LIMITED PARTNER
since Oct 2023
75% or moreDomestic Entity
KKR GROUP CO. INC. Control
Indirect owner via KKR GROUP HOLDINGS L.P.
LIMITED PARTNER
since Oct 2023
75% or moreDomestic Entity
KKR GROUP CO. INC. Control
Indirect owner via KKR GROUP HOLDINGS CORP.
SHAREHOLDER
since Oct 2023
75% or moreDomestic Entity
KKR GROUP HOLDINGS CORP. Control
Indirect owner via KKR GROUP PARTNERSHIP L.P.
GENERAL PARTNER
since Oct 2023
General partner, trustee or managerDomestic Entity
KKR GROUP HOLDINGS CORP. Control
Indirect owner via KKR GROUP HOLDINGS L.P.
GENERAL PARTNER
since Oct 2023
General partner, trustee or managerDomestic Entity
KKR GROUP HOLDINGS L.P. Control
Indirect owner via KKR GROUP PARTNERSHIP L.P.
LIMITED PARTNER
since Oct 2023
25–50%Domestic Entity
KKR GROUP PARTNERSHIP L.P. Control
Indirect owner via KKR GROUP ASSETS HOLDINGS II L.P.
LIMITED PARTNER
since Oct 2023
75% or moreForeign Entity
KKR GROUP PARTNERSHIP L.P. Control
Indirect owner via KKR GROUP ASSETS GP II LLC
SOLE MEMBER
since Oct 2023
75% or moreForeign Entity
PETROCHEILOS, GEORGIOS, NMN Control
Indirect owner via CATALIO CAPITAL GP, LLC
MEMBER
since Jun 2020
50–75%Individual
PETROCHEILOS, GEORGIOS, NMN Control
Indirect owner via STONEBIRD PARTNERS, LP
MEMBER
since Jan 2023
50–75%Individual
VOGELSTEIN, RACHEL, JACOB Control
Indirect owner via CATALIO CAPITAL GP, LLC
MEMBER
since Jun 2020
50–75%Individual
VOGELSTEIN, RACHEL, JACOB Control
Indirect owner via STONEBIRD PARTNERS, LP
MEMBER
since Jan 2023
50–75%Individual
Ownership & leadership changes · 4 filings with changes since Sep 2, 2020

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Nov 1, 2023 filing
  • AddedKKR & CO. INC. · SHAREHOLDER · 75% or more · indirect via KKR GROUP CO. INC. · control person
  • AddedKKR CATALINA GP LLC · GENERAL PARTNER · General partner, trustee or manager · indirect via KKR CATALINA HOLDINGS L.P. · control person
  • AddedKKR CATALINA HOLDINGS L.P. · LIMITED PARTNER · 25–50% · control person
  • AddedKKR GROUP ASSETS GP II LLC · GENERAL PARTNER · General partner, trustee or manager · indirect via KKR GROUP ASSETS HOLDINGS II L.P. · control person
  • AddedKKR GROUP ASSETS HOLDINGS II L.P. · LIMITED PARTNER · 75% or more · indirect via KKR CATALINA HOLDINGS L.P. · control person
  • AddedKKR GROUP ASSETS HOLDINGS II L.P. · SOLE MEMBER · 75% or more · indirect via KKR CATALINA GP LLC · control person
  • AddedKKR GROUP CO. INC. · LIMITED PARTNER · 75% or more · indirect via KKR GROUP HOLDINGS L.P. · control person
  • AddedKKR GROUP CO. INC. · SHAREHOLDER · 75% or more · indirect via KKR GROUP HOLDINGS CORP. · control person
  • AddedKKR GROUP HOLDINGS CORP. · GENERAL PARTNER · General partner, trustee or manager · indirect via KKR GROUP PARTNERSHIP L.P. · control person
  • AddedKKR GROUP HOLDINGS CORP. · GENERAL PARTNER · General partner, trustee or manager · indirect via KKR GROUP HOLDINGS L.P. · control person
  • AddedKKR GROUP HOLDINGS L.P. · LIMITED PARTNER · 25–50% · indirect via KKR GROUP PARTNERSHIP L.P. · control person
  • AddedKKR GROUP PARTNERSHIP L.P. · LIMITED PARTNER · 75% or more · indirect via KKR GROUP ASSETS HOLDINGS II L.P. · control person
  • AddedKKR GROUP PARTNERSHIP L.P. · SOLE MEMBER · 75% or more · indirect via KKR GROUP ASSETS GP II LLC · control person
  • ChangedCATALIO CAPITAL GP, LLC · ownership 50–75% → Less than 5%
Mar 30, 2023 filing
  • No longer listedVOGELSTEIN, RACHEL, JACOB · MANAGER OF THE GENERAL PARTNER · 50–75% · control person · listed since Jun 2020
  • AddedPETROCHEILOS, GEORGIOS, NMN · MEMBER · 50–75% · indirect via STONEBIRD PARTNERS, LP · control person
  • AddedSTONEBIRD PARTNERS, LP · LIMITED PARTNER · 50–75% · control person
  • AddedVOGELSTEIN, RACHEL, JACOB · MEMBER · 50–75% · indirect via CATALIO CAPITAL GP, LLC · control person
  • AddedVOGELSTEIN, RACHEL, JACOB · MEMBER · 50–75% · indirect via STONEBIRD PARTNERS, LP · control person
  • ChangedCATALIO CAPITAL GP, LLC · ownership Less than 5% → 50–75%
  • ChangedPETROCHEILOS, GEORGIOS, NMN · indirect via CATALIO CAPITAL GP, LLC: ownership 25–50% → 50–75%
Mar 31, 2022 filing
  • ChangedPETROCHEILOS, GEORGIOS, NMN · indirect via CATALIO CAPITAL GP, LLC: ownership 50–75% → 25–50%
  • ChangedVOGELSTEIN, RACHEL, JACOB · ownership 75% or more → 50–75%
Jun 30, 2021 filing
  • AddedMALTSEVA, OLGA, EDUARDOVNA · CHIEF COMPLIANCE OFFICER AND HEAD OF OPERATIONS · Less than 5%
Sep 2, 2020 filing (earliest on record)
  • ListedCATALIO CAPITAL GP, LLC · GENERAL PARTNER · Less than 5% · control person
  • ListedPETROCHEILOS, GEORGIOS, NMN · MEMBER · 50–75% · indirect via CATALIO CAPITAL GP, LLC · control person
  • ListedVOGELSTEIN, RACHEL, JACOB · MANAGER OF THE GENERAL PARTNER · 75% or more · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Catalio Capital Management, LP Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 AVALYN PHARMACEUTICALS INC AVLN 05348Y105 $55.2M 10.37% 1,675,830 SH
2 JOHNSON & JOHNSON JNJ 478160104 $35.3M 6.63% 138,946 SH
3 GILEAD SCIENCES INC GILD 375558103 $34.0M 6.39% 269,309 SH
4 BRIDGEBIO PHARMA INC BBIO 10806X102 $33.9M 6.37% 455,041 SH
5 SYNDAX PHARMACEUTICALS INC SNDX 87164F105 $26.6M 4.99% 1,215,698 SH
6 DEFINIUM THERAPEUTICS INC DFTX 24477V105 $26.5M 4.97% 562,672 SH
7 BRISTOL-MYERS SQUIBB CO BMY 110122108 $23.8M 4.47% 412,961 SH
8 PARABILIS MEDICINES INC PBLS 698955101 $22.6M 4.24% 824,043 SH
9 NATERA INC NTRA 632307104 $22.3M 4.19% 82,181 SH
10 INCYTE CORP INCY 45337C102 $21.7M 4.08% 191,627 SH
11 SEPTERNA INC SEPN 81734D104 $18.0M 3.37% 536,152 SH
12 MINERALYS THERAPEUTICS INC MLYS 603170101 $17.5M 3.29% 648,722 SH
13 HEARTFLOW INC HTFL 42238D107 $17.1M 3.21% 583,055 SH
14 CORVUS PHARMACEUTICALS INC CRVS 221015100 $16.1M 3.03% 1,080,888 SH
15 STRUCTURE THERAPEUTICS INC GPCR 86366E106 $14.8M 2.79% 276,550 SH
16 PROTAGONIST THERAPEUTICS INC PTGX 74366E102 $13.1M 2.46% 106,799 SH
17 DISC MEDICINE INC IRON 254604101 $11.7M 2.19% 159,384 SH
18 EDWARDS LIFESCIENCES CORP EW 28176E108 $11.3M 2.12% 124,778 SH
19 AXSOME THERAPEUTICS INC. AXSM 05464T104 $10.6M 1.99% 43,182 SH
20 ULTRAGENYX PHARMACEUTICAL IN RARE 90400D108 $10.6M 1.98% 316,252 SH
21 KAILERA THERAPEUTICS INC KLRA 482931102 $10.3M 1.94% 468,750 SH
22 KARYOPHARM THERAPEUTICS INC KPTI 48576U205 $9.2M 1.73% 940,855 SH
23 ODYSSEY THERAPEUTICS INC ODTX 67613T104 $8.6M 1.61% 457,839 SH
24 ASCENDIS PHARMA A/S ASND K08588103 $8.5M 1.59% 31,759 SH
25 KARDIGAN INC KARD 485925101 $7.5M 1.40% 312,500 SH
26 ELEDON PHARMACEUTICALS INC ELDN 28617K101 $6.7M 1.26% 1,695,071 SH
27 4D MOLECULAR THERAPEUTICS IN FDMT 35104E100 $6.3M 1.18% 471,254 SH
28 VERADERMICS INC MANE 922967104 $5.6M 1.06% 45,856 SH
29 DYNE THERAPEUTICS INC DYN 26818M108 $5.4M 1.02% 244,929 SH
30 FRACTYL HEALTH INC GUTS 35168W103 $4.9M 0.92% 6,168,749 SH
31 IMMUNOCORE HLDGS PLC IMCR 45258D105 $4.7M 0.88% 148,045 SH
32 DIANTHUS THERAPEUTICS INC DNTH 252828108 $3.2M 0.60% 32,941 SH
33 BRIDGEBIO ONCOLOGY THERAPEUT BBOT 107924102 $2.4M 0.46% 318,407 SH
34 PROTARA THERAPEUTICS INC TARA 74365U107 $2.0M 0.37% 520,148 SH
35 HYPERFINE INC HYPR 44916K106 $1.8M 0.33% 1,320,041 SH
36 ATAIBECKLEY INC ATAI 04650F101 $1.0M 0.19% 196,858 SH
37 METAGENOMI THERAPEUTICS INC MGX 59102M104 $629.5K 0.12% 528,993 SH
38 OUTSET MED INC OM 690145206 $511.0K 0.10% 118,279 SH
39 FAETH THERAPEUTICS INC FTH 81728A207 $367.9K 0.07% 14,718 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $532.1M 39 0001958125-26-000005
2026-03-31 2026-05-15 $478.7M 41 0001958125-26-000003
2025-12-31 2026-02-17 $565.8M 45 0001958125-26-000002
2025-12-31 2026-09-02 $565.8M 45 0001958125-26-000007
2025-09-30 2025-11-14 $540.9M 38 0001958125-25-000009
Filer Information
Address
512 W. 22ND STREET
5TH FLOOR
NEW YORK, NY 10011
Phone
(410) 989-6168
Filing Manager
Catalio Capital Management, LP
NEW YORK, NY
Signatory
Olga Maltseva
Chief Compliance Officer and Head of Operations